Related Experiment Video
Updated: Jun 4, 2025

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
CUL4B protects kidneys from acute injury by restraining p53/PAI-1 signaling
Kaixuan Liu1, Xiaoyu Hao1, Yangfan Gao2
1Key Laboratory of Experimental Teratology, Ministry of Education, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Abstract:
Acute kidney injury (AKI) caused by nephrotoxins, ischemia reperfusion (IR) or sepsis is associated with high morbidity and mortality. Unveiling new mechanisms underlying AKI can help develop new therapeutic strategy. Cullin 4B (CUL4B) is a scaffold protein in the CUL4B-RING E3 ubiquitin ligase (CRL4B) complex. Here, we demonstrate that CUL4B can protect kidneys from acute injury induced by cisplatin and IR. CUL4B is upregulated in mouse tubular epithelial cells (TECs) after cisplatin treatment or IR. Loss of CUL4B in kidneys exacerbates renal injury, inflammation, and apoptosis of TECs caused by cisplatin and IR. Transcriptome analysis reveals that Cul4b deficiency enhances injury-induced PAI-1 expression. CUL4B suppresses PAI-1 expression by promoting polyubiquitination and degradation of p53. Inhibition of either PAI-1 or p53 can prevent the aggravated renal injury and inflammation caused by loss of CUL4B. Our work has identified the kidney-protective role of CUL4B against acute injury.
Insights
Cullin 4B (CUL4B) protects kidneys from acute injury by suppressing PAI-1 expression. Loss of CUL4B worsens kidney damage, inflammation, and cell death, highlighting its protective role in acute kidney injury.
Area of Science:
- Nephrology
- Molecular Biology
- Cellular Biology
Background:
- Acute kidney injury (AKI) presents significant morbidity and mortality.
- Understanding novel mechanisms is crucial for developing therapeutic strategies.
- Cullin 4B (CUL4B) is a key component of the CRL4B E3 ubiquitin ligase complex.
Purpose of the Study:
- To investigate the role of CUL4B in kidney protection against acute injury.
- To elucidate the molecular mechanisms by which CUL4B exerts its protective effects.
Main Methods:
- Utilized mouse models of cisplatin-induced and ischemia-reperfusion (IR) kidney injury.
- Assessed renal injury, inflammation, and apoptosis in wild-type and Cul4b-deficient kidneys.
- Performed transcriptome analysis to identify affected pathways.
- Investigated the interaction between CUL4B, p53, and PAI-1.
Main Results:
- CUL4B expression is upregulated in tubular epithelial cells (TECs) following cisplatin or IR injury.
- Loss of CUL4B exacerbates renal injury, inflammation, and TEC apoptosis.
- Cul4b deficiency leads to increased PAI-1 expression.
- CUL4B suppresses PAI-1 by promoting p53 polyubiquitination and degradation.
- Inhibiting PAI-1 or p53 ameliorates the exacerbated injury in Cul4b-deficient kidneys.
Conclusions:
- CUL4B plays a significant kidney-protective role against acute injury.
- CUL4B mitigates AKI by suppressing PAI-1 expression via p53 degradation.
- Targeting the CUL4B-p53-PAI-1 axis may offer a therapeutic avenue for AKI.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
The JAK-STAT Signaling Pathway
DNA Damage can Stall the Cell Cycle

